These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18793901)

  • 21. Stroke risk assessment for atrial fibrillation: hospital-based stroke risk assessment and intervention program.
    Jackson SL; Peterson GM
    J Clin Pharm Ther; 2011 Feb; 36(1):71-9. PubMed ID: 21198722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
    Beckman JA
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The antithrombotic treatment in the secondary prevention of ischemic stroke: strategy and tactic issues].
    Gudkova VV; Stakhovskaia LV; Shanina TV; Meshkova KS; Shekhovtsova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):87-94. PubMed ID: 22611687
    [No Abstract]   [Full Text] [Related]  

  • 25. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
    Yu HC; Tsai YF; Chen MC; Yeh CH
    Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary prevention of stroke: more than just aspirin or warfarin.
    Chatterjee K; Fall S; Barer D
    Age Ageing; 2004 May; 33(3):218-20. PubMed ID: 15082424
    [No Abstract]   [Full Text] [Related]  

  • 27. Stroke salvage using a suction thrombectomy device and tissue plasminogen activator.
    Thompson C; Murphy T; Hampson C
    Med Health R I; 2012 Feb; 95(2):59-61. PubMed ID: 22474879
    [No Abstract]   [Full Text] [Related]  

  • 28. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
    Pepine CJ
    Ann Med; 2010; 42(1):19-35. PubMed ID: 20092398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.
    O'Donnell M; Weitz JI
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S72-82. PubMed ID: 15152749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk.
    Freudenberger RS; Fuster V
    Mt Sinai J Med; 1996; 63(5-6):342-58. PubMed ID: 8898540
    [No Abstract]   [Full Text] [Related]  

  • 33. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic therapy for stroke prevention in atrial fibrillation.
    Go AS; Fang MC; Singer DE
    Prog Cardiovasc Dis; 2005; 48(2):108-24. PubMed ID: 16253651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antithrombotic and thrombolytic treatments: current concepts from the North American guidelines and French practice].
    J Mal Vasc; 2005 Sep; 30 Spec No 2():2S8-2S79. PubMed ID: 16392541
    [No Abstract]   [Full Text] [Related]  

  • 36. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic agents in the prevention of ischemic stroke.
    Bousser MG
    Cerebrovasc Dis; 2009; 27 Suppl 3():12-9. PubMed ID: 19439936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symposium on thrombosis and antithrombotic therapy--1986.
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):1B-167B. PubMed ID: 3782650
    [No Abstract]   [Full Text] [Related]  

  • 39. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome.
    Paciaroni M; Agnelli G; Caso V; Venti M; Milia P; Silvestrelli G; Parnetti L; Biagini S
    J Thromb Haemost; 2005 Jun; 3(6):1218-23. PubMed ID: 15892862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic and thrombolytic therapy for ischemic stroke.
    Cornett O; Ocava LC; Singh M; Malhotra S; Rosenbaum DM
    Cardiol Clin; 2008 May; 26(2):251-65, vii. PubMed ID: 18406998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.